Skip to main content
Veterinary Medicines

LINCO-SPECTIN (50+100)MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ

Authorised
  • Spectinomycin sulfate
  • Lincomycin hydrochloride

Product identification

Medicine name:
LINCO-SPECTIN (50+100)MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
  • Spectinomycin sulfate
  • Lincomycin hydrochloride
Target species:
  • Sheep
  • Goat
  • Cattle (calf)
  • Pig
  • Chicken
  • Turkey
  • Dog
  • Cat
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Spectinomycin sulfate
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Lincomycin hydrochloride
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Sheep
      • Meat and offal
        14
        day
      • Milk
        2
        day
    • Goat
      • Meat and offal
        14
        day
      • Milk
        2
        day
    • Cattle (calf)
      • Meat and offal
        14
        day
      • Milk
        2
        day
    • Pig
      • Meat and offal
        14
        day
    • Chicken
      • Meat and offal
        14
        day
    • Turkey
      • Meat and offal
        14
        day
    • Dog
      • Not applicable
        no withdrawal period
    • Cat
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF52
Authorisation status:
  • Valid
Authorised in:
  • Greece
Available in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Hellas S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium SA
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 56768/16-06-2021/K-0015804
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."